Dr. Tager addresses the following questions: How do nintedanib and pirfenidone work? Which targets are being investigated in the search for new drugs? Which drug candidates might emerge in the near future? Are there drugs for other indications that might be useful for IPF?
For more IPF education, please visit [ Ссылка ]
